South Korea Cell Separation Market

The South Korea Cell Separation Market Size is anticipated to grow from USD 212.3 Million in 2025 and is expected to reach around USD 688.9 Million by 2035. According to Decision Advisors, studies show that automation is the leading growth catalyst in the South Korea cell separation industry, representing nearly 42-48% of global market impact share. Miltenyi Biotec maintains a dominant market presence with an estimated USD 120–180 million annual revenues and approximately 22–28.3% share in the South Korea market, significantly shaping industry expansion and strategic direction.

Market Snapshot

• South Korea Cell Separation Market Size (2025): USD 212.3 Million
• Projected South Korea Cell Separation Market Size (2035): 688.9 Million
• South Korea Cell Separation Market Compound Annual Growth Rate (CAGR): 12.49%
• Base Year: 2025
• Historical Period: 2021–2024
• Forecast Period: 2026–2035

Market Overview/Introduction

The South Korean cell separation market is focused on the use of cell separation technology within the field of biotechnology, which uses the biophysical characteristics of cells to separate cell types from biological sample sources such as blood or tissue. The major applications for this technology are for cancer research in relation to circulating tumour cells, isolation of stem cells for regenerative therapy, biopharmaceutical production through biologics, and in vitro diagnostics for genetic and immunological purposes. Recent developments in the industry are microfluidic technologies, artificial intelligence integration in flow cytometry, MACS/FACS automation, and acoustic separation techniques. Future developments are likely to come in response to increasing regulation around regenerative medicine, advances in targeted oncology research, and increasing investment into research and development.

• South Korea cell separation market is strengthened by a (USD 34.3Billion) strategic industry fund, boosting biopharma, biotech infrastructure, and regenerative medicine ecosystems, enhancing innovation, manufacturing capacity, and long-term competitiveness in South Korea.

Notable Insights: -

1. By product type, the consumables segment held a dominant position with 63.4% in terms of market share in 2025.
2. By technology type, fluorescence-activated cell sorting segment is the dominating accounting for over 39.3% of the Germany market share in 2025.
3. The compound annual growth rate of the South Korea Cell Separation Market is 12.49%.
4. The market is likely to achieve a valuation of USD 688.9 Million by 2035.

What is role of technology in grooming the market?

The South Korea cell separation market experiences technology is very important since it acts as an enabling factor. The development of technology in South Korea, especially through innovations in fluorescence-activated cell sorting techniques, microfluidic applications, diagnostic applications of artificial intelligence, and automated cell separation, has led to increased effectiveness and efficiency.

Market Drivers

The South Korea cell separation market is highly influenced by extensive research and development capabilities and the proactive investment in biotechnologies on the part of both the government and private sectors. The existence of favorable regulations, reimbursement initiatives, and funding programs that support personalized medicines helps boost growth. Increasing occurrences of chronic diseases such as cancer, heart disease, and autoimmune disease are major factors driving up the demand for accurate diagnosis and treatment of cells through separation. The fast progress in the field of stem cell research and regenerative biology necessitates efficient cell separation technologies, whereas the proliferation of biopharmaceutical drugs and personalized medicines drive the need for more automation and scalability of separation technologies.

Restrain

The South Korea cell separation market faces structural constraints that act as barriers to its growth. First, heavy investment costs associated with the use of technologies such as FACS and MACS, coupled with constant reagent usage, raise financial pressure on research organizations and biotech companies. Secondly, the threat of cell damage, cell contamination, and lowered viability levels poses difficulties in meeting the GMP and regulatory requirements. Furthermore, dependency on the procurement of foreign raw materials and supplies limits the ability of the sector to scale up and commercialize its advanced cell separation technology.

Strategies to Implement for Growth of the Market

The South Korea cell separation market is involves improving the domestic bioprocessing environment by increasing localization of consumables, reagents, and high-tech cell sorting devices. Enhanced collaboration between public organizations and the private sector coupled with an increase in biotechnology financing will fast-track innovations in the fields of regenerative medicine and diagnostics.

Market Segmentation

The South Korea Cell Separation Market share is classified into product, technology, and application

• The consumables segment dominated the market in 2024, and is projected to grow at a substantial CAGR of approximately 9.2% during the forecast period.

Based on the product type, the cell separation market is divided into consumables, instruments. Among these, the consumables segment dominated the market in 2024, and is projected to grow at a substantial CAGR of approximately 9.2% during the forecast period. It is due to the recurring demand for reagents, kits, and single-use systems. Strong regenerative medicine growth, clinical applications, and biotech expansion reinforce high-volume usage, supporting sustained revenue generation and scalable bioprocessing efficiency across South Korea.

• The fluorescence-activated cell sorting segment accounted for the largest share in 2024, and is anticipated to grow at a significant CAGR of approximately 7.3% during the forecast period.

Based on the technology, the cell separation market is divided into immunomagnetic cell separation, fluorescence-activated cell sorting (FACS), microfluidic cell separation, density gradient centrifugation, others. Among these, the fluorescence-activated cell sorting segment accounted for the largest share in 2024, and is anticipated to grow at a significant CAGR of approximately 7.3% during the forecast period. It is dominating because the high-precision cell analysis, oncology research, and regenerative medicine applications. Strong adoption in clinical laboratories and biotech R&D enhances segmentation accuracy, boosting advanced biomedical innovation and market expansion across South Korea.

• The cancer research segment dominated the market in 2024, and is projected to grow at a substantial CAGR during the forecast period.

Based on the application, the cell separation market is divided into stem cell research, cancer research, immunology, neuroscience, others. Among these, the cancer research segment dominated the rising oncology burden, precision medicine adoption, and strong government funding. Advanced cell sorting technologies support tumour analysis, immunotherapy development, and clinical innovation, strengthening biomedical research ecosystem across South Korea.

Recent Development

• In April 2026, South Korea cell separation market strengthens with MFDS approval of 15 cell and gene therapies, driving regenerative medicine growth, and expanding advanced cell processing demand across South Korea ecosystem.
• In May 2025, South Korea cell separation market expands through $1.2Billion biotechnology innovation funding, strengthening R&D, commercialization, and advanced therapeutics, supporting regenerative medicine growth and enhancing cellular processing infrastructure across South Korea’s biohealth ecosystem.

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the South Korea cell separation market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in South Korea Cell Separation Market

1. Samsung Biologics
2. Celltrion
3. GC Biopharma
4. Medipost
5. Theragen Etex
6. Genexine
7. TiumBio

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the South Korea, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the South Korea cell separation market based on the below-mentioned segments

South Korea Cell Separation Market, By Product

• • Consumables
  • Instruments

South Korea Cell Separation Market, By Technology

• • Immunomagnetic Cell Separation
  • Fluorescence-Activated Cell Sorting (FACS)
  • Microfluidic Cell Separation
  • Density Gradient Centrifugation
  • Others

South Korea Cell Separation Market, By Application

• • Stem Cell Research
  • Cancer Research
  • Immunology
  • Neuroscience
  • Others

Frequently Asked Questions (FAQ)

1. Which market segment leads the South Korea cell separation market?

Consumables lead the South Korea cell separation market because of their constant demand from laboratories due to the frequent laboratory experiments and growing applications in bioprocesses and cell therapy processes.

2. Why is FACS relevant in this market?

Fluorescence-activated cell sorting leads the market because of its precision, ability to process more than one cell at once, and widespread applications in the fields of oncology, immunology, and stem cell studies.

3. How does cancer research influence this market?

Cancer research leads the market because of the increasing number of cancers among the population, the growing funding in R&D activities, and the growing popularity of precision oncology and immunotherapies.

4. What are some limitations of this market?

Some limitations that affect the market include expensive equipment, high dependency on imported consumables, complex approval procedures for new products, and risks of damaging cells during their processing.